Literature DB >> 18751387

Restoration of FGF receptor type 2 enhances radiosensitivity of hormone-refractory human prostate carcinoma PC-3 cells.

Akio Matsubara1, Jun Teishima, Suichinov Mirkhat, Hiroaki Yasumoto, Hideki Mochizuki, Mitsuhiro Seki, Kazuaki Mutaguchi, Wallace L Mckeehan, Tsuguru Usui.   

Abstract

BACKGROUND: This study was undertaken to investigate the radiosensitizing effects of fibroblast growth factor receptor 2IIIb (FGFR2IIIb) in androgen-independent human prostate carcinoma PC-3 cells devoid of normally resident epithelial cell FGFR2IIIb.
MATERIALS AND METHODS: A clonal line of PC-3 cells expressing FGFR2IIIb was established by stable transfection. Clonogenic cell survival, apoptosis and cell cycle distribution with and without gamma-irradiation were then compared between FGFR2IIIb-expressing PC-3 cells and control cells mock-transfected with vector alone.
RESULTS: Gamma-irradiation resulted in an increase of clonogenic cell death concurrent with enhanced apoptosis and cell cycle arrest in the G2/M-phase in both transfected and untransfected cells. A quantitative analysis of all three parameters indicated that cells expressing FGFR2IIIb were significantly more sensitive to irradiation than control cells.
CONCLUSION: These results indicate that restoration of FGFR2IIIb to PC-3 cells enhances their sensitivity to irradiation through acceleration of apoptosis and cell cycle arrest.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18751387

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  FGFR1 abrogates inhibitory effect of androgen receptor concurrent with induction of androgen-receptor variants in androgen receptor-negative prostate tumor epithelial cells.

Authors:  Masashi Kobayashi; Yanqing Huang; Chengliu Jin; Yongde Luo; Tetsuji Okamoto; Fen Wang; Wallace L McKeehan
Journal:  Prostate       Date:  2011-03-28       Impact factor: 4.104

Review 2.  2b or Not 2b: How Opposing FGF Receptor Splice Variants Are Blocking Progress in Precision Oncology.

Authors:  Richard J Epstein; Li Jun Tian; Yan Fei Gu
Journal:  J Oncol       Date:  2021-04-30       Impact factor: 4.375

Review 3.  Fibroblast Growth Factor Family in the Progression of Prostate Cancer.

Authors:  Jun Teishima; Tetsutaro Hayashi; Hirotaka Nagamatsu; Koichi Shoji; Hiroyuki Shikuma; Ryoken Yamanaka; Yohei Sekino; Keisuke Goto; Shogo Inoue; Akio Matsubara
Journal:  J Clin Med       Date:  2019-02-04       Impact factor: 4.241

Review 4.  Palifermin for the protection and regeneration of epithelial tissues following injury: new findings in basic research and pre-clinical models.

Authors:  Paul W Finch; Lawrence J Mark Cross; Daniel F McAuley; Catherine L Farrell
Journal:  J Cell Mol Med       Date:  2013-09       Impact factor: 5.310

5.  Fibroblast growth factor receptor 4 induced resistance to radiation therapy in colorectal cancer.

Authors:  Mohamed A Ahmed; Edgar Selzer; Wolfgang Dörr; Gerd Jomrich; Felix Harpain; Gerd R Silberhumer; Leonhard Müllauer; Klaus Holzmann; Bettina Grasl-Kraupp; Michael Grusch; Walter Berger; Brigitte Marian
Journal:  Oncotarget       Date:  2016-10-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.